UBS Maintains a 'Buy' on Cardinal Health (CAH); Color on Safeway Contract
Tweet Send to a FriendGet Alerts CAH Hot Sheet
Price: $48.02 +0.48%
Rating Summary:
8 Buy, 4 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 21 | Down: 43 | New: 13
Rating Summary:
8 Buy, 4 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 21 | Down: 43 | New: 13
Trade CAH Now!
UBS maintains a 'Buy' on Cardinal Health (NYSE: CAH) price target lowered from $51 to $50.
Analyst, Steven Valiquette, said, "CAH management officially confirmed what was already generally known that the Safeway (NYSE: SWY) drug distribution contract was won from McKesson (NYSE: MCK). Mgmt clarified the contract includes both brands and generics (some conjectured that SWY may revert back to buying generics direct, but CAH refuted this notion). This ~$3 bil annual contract should add $0.09-0.11 EPS for CAH (w/ est. 1.00-1.25% net margin). CAH also confirmed both its Walgreen (NYSE: WAG) & CVS (NYSE: CVS) contracts are set to renew in mid-‘13." (UBS raises FY13 EPS from $3.65 to $3.58)
For an analyst ratings summary and ratings history on Cardinal Health click here. For more ratings news on Cardinal Health click here.
Shares of Cardinal Health closed at $43.33 yesterday, with a 52 week range of $37.53-$47.06.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Analyst, Steven Valiquette, said, "CAH management officially confirmed what was already generally known that the Safeway (NYSE: SWY) drug distribution contract was won from McKesson (NYSE: MCK). Mgmt clarified the contract includes both brands and generics (some conjectured that SWY may revert back to buying generics direct, but CAH refuted this notion). This ~$3 bil annual contract should add $0.09-0.11 EPS for CAH (w/ est. 1.00-1.25% net margin). CAH also confirmed both its Walgreen (NYSE: WAG) & CVS (NYSE: CVS) contracts are set to renew in mid-‘13." (UBS raises FY13 EPS from $3.65 to $3.58)
For an analyst ratings summary and ratings history on Cardinal Health click here. For more ratings news on Cardinal Health click here.
Shares of Cardinal Health closed at $43.33 yesterday, with a 52 week range of $37.53-$47.06.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Wedbush Downgrades XenoPort (XNPT) to Neutral
- Morgan Stanley Says Tesla (TSLA) 'Top Pick in U.S. Autos'
- Wells Fargo Downgrades Ruby Tuesday (RT) to Market Perform
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT ChangeRelated Entities
UBS
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
